UCLA DA 225.37: Execution of Documents Related to Material Transfer Agreements

Date:	April 04, 2011 Print
From:	Vice Provost, Intellectual Property & Industry Relations Kathryn Atchison
To:	Director, Licensing Emily Loughran Director, Industry Sponsored Research and Material Transfer Lillian L. Smith Assistant Director, Industry Sponsored Research and Material Transfer Brian Roe Material Transfer Administrator & Industry Contract Officer Kathy zzzWrobel MTA Analyst Christopher Tomera Senior Administrative Analyst, Molecular & Medical Pharmacology Benjamin Lehrer
References:	UC DA 2036 (To Solicit and Accept or Execute Certain Extramural Grants and Contracts) to Chancellors, dated March 10, 1995; University of California Contract and Grant Manual; National Institutes of Health (NIH) – General Information on Uniform Biological Material Transfer Agreements (UBMTA); University of California Patent Policy
Supersedes:	UCLA DA 225.36 (Execution of Documents Related to Material Transfer Agreements) to Directors Loughran and Smith, et al., dated 6/9/2010.

Effective as of the date, above, I hereby delegate to you, in your respective areas of responsibility, the authority to execute Material Transfer Agreements (MTA) and Uniform Biological Material Transfer Agreements (UBMTA) in accordance with the UC policies, and as specified in the following Delegated Authority Matrix:

Material Transfer Agreements and Uniform Biological Material Transfer Agreements
Delegated Authority Matrix

To Execute Outgoing and Incoming MTAs and UBMTAs and Propose Appropriate Exceptions to UC Policies:
To Execute Outgoing and Incoming UBMTAs:
To Execute Outgoing and Incoming MTAs:
Director, Licensing	X	X	X
Director, Industry Sponsored Research	X	X	X
Assistant Director, Industry Sponsored Research	X	X	X
Material Transfer Administrator & Industry Contract Officer	X	X	n/a
MTA Analyst	n/a	X	n/a
Senior Administrative Analyst	n/a	X	n/a

For purposes of this delegation, an MTA is a written agreement entered into by a provider and a recipient of research material. The intent of the MTA is to protect the intellectual property rights and other rights of the parties while permitting research with the material to proceed. The most common subjects of material transfer agreements are biological materials and chemical compounds. However, MTAs may also be used to transfer other types of materials including, but not limited to, databases and software. The provider of the materials does not provide research funding for the project. The materials are not to be used in humans.

There are three forms of material transfer that commonly arise at academic institutions, each calling for different terms and conditions. They are: material transfer between academic institutions; material transfer from industry to UCLA; and material transfer from UCLA to industry. To encourage the process of sharing research tools between scientists, the NIH and the Association of University Technology Managers (AUTM) have developed standard language to simplify material transfers between academic institutions. The Uniform Biological Material Transfer Agreement (UBMTA) shall generally be used for such material transfers whenever possible.

This delegation is being issued due to an organization change and there are no substantive changes to the delegation being superseded. This authority may not be further redelegated.

cc:	Chancellor Executive Vice Chancellor & Provost Vice Chancellor, Research Assistant Vice Chancellor, Research Manager, Administrative Policies & Delegations